Screen test
Genetic screening of children with autism is critical to designing more effective interventions and treatment, says a pediatrician.
Efforts to ease the symptoms of autism are beginning to ramp up, with promising candidates in various stages of testing.
Genetic screening of children with autism is critical to designing more effective interventions and treatment, says a pediatrician.
Speech-generating devices are a beneficial intervention for people with autism who cannot speak or sign, according to two studies published in the past few months.
Parents of children with autism choose treatment options based on what they believe caused the disorder, according to a French study. More education about autism could help them make better choices.
Adults with autism get better at recognizing faces after they are trained to observe faces as a whole, instead of focusing on individual features, according to a study published 12 April in the Journal of Autism and Developmental Disorders.
Mice lacking CNTNAP2, a gene linked to autism and language impairment, show behaviors and brain abnormalities that reflect those seen in people with disorder, according to new findings presented Thursday at the International Meeting for Autism Research in San Diego.
Variants of three genes involved in a metabolic pathway together raise the risk of autism, according to a study published 5 March in the Journal of Neurodevelopmental Disorders.
Large studies on the epidemiology and genetics of epilepsy and autism have uncovered commonalities between the two disorders. But scientists are only beginning to untangle the biological roots of the overlap.
Good mouse models of autism, and accurate tests to assay their phenotypes, are key to both narrowing down a cause and developing effective treatments, argues expert Jacqueline Crawley.
Short questionnaires that parents can fill out at a pediatrician’s office flag early signs of autism in infants and toddlers well before the disorder is usually diagnosed, according to two new studies.
An autism-associated gene variant of glyoxalase 1, or GLO1, leads to the buildup of a compound that is toxic to neurons, according to a study published 12 April in Autism Research.